Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Urologic Oncology
|
October 24, 2021
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series
Francesco Barletta, Armando Stabile, Elio Mazzone, et al.
European Radiology
|
February 6, 2026
Inter- and intra-rater variability of MRI-based lesion size measurements in active surveillance for prostate cancer: a multicentre study
Cameron Englman, Busola Adebusoye, Michele Cosenza, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 28, 2023
Diagnostic accuracy of fully hybrid [<sup>68</sup>Ga]Ga-PSMA-11 PET/MRI and [<sup>68</sup>Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial
Samuele Ghezzo, Paola Mapelli, Ana Maria Samanes Gajate, et al.
World Journal of Urology
|
September 23, 2022
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database
Francesco Barletta, Elio Mazzone, Armando Stabile, et al.
Frontiers in Medicine
|
March 13, 2023
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on <sup>68</sup>Ga-PSMA PET images
Samuele Ghezzo, Sofia Mongardi, Carolina Bezzi, et al.
European Urology Oncology
|
May 18, 2019
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer
Armando Stabile, Paolo Dell'Oglio, Francesco De Cobelli, et al.
Bioengineering (Basel, Switzerland)
|
August 26, 2023
[<sup>68</sup>Ga]Ga-PSMA and [<sup>68</sup>Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration
Samuele Ghezzo, Ilaria Neri, Paola Mapelli, et al.
La Radiologia Medica
|
May 7, 2025
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging
Tommaso Russo, Leonardo Quarta, Francesco Pellegrino, et al.
BJU International
|
July 8, 2026
Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study
Donato Cannoletta, Giorgio Brembilla, Mattia Longoni, et al.
European Urology Oncology
|
May 18, 2019
Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer
Armando Stabile, Paolo Dell'Oglio, Giorgio Gandaglia, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Urologic Oncology
|
October 24, 2021
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series
Francesco Barletta, Armando Stabile, Elio Mazzone, et al.
European Radiology
|
February 6, 2026
Inter- and intra-rater variability of MRI-based lesion size measurements in active surveillance for prostate cancer: a multicentre study
Cameron Englman, Busola Adebusoye, Michele Cosenza, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 28, 2023
Diagnostic accuracy of fully hybrid [<sup>68</sup>Ga]Ga-PSMA-11 PET/MRI and [<sup>68</sup>Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial
Samuele Ghezzo, Paola Mapelli, Ana Maria Samanes Gajate, et al.
World Journal of Urology
|
September 23, 2022
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database
Francesco Barletta, Elio Mazzone, Armando Stabile, et al.
Frontiers in Medicine
|
March 13, 2023
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on <sup>68</sup>Ga-PSMA PET images
Samuele Ghezzo, Sofia Mongardi, Carolina Bezzi, et al.
European Urology Oncology
|
May 18, 2019
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer
Armando Stabile, Paolo Dell'Oglio, Francesco De Cobelli, et al.
Bioengineering (Basel, Switzerland)
|
August 26, 2023
[<sup>68</sup>Ga]Ga-PSMA and [<sup>68</sup>Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration
Samuele Ghezzo, Ilaria Neri, Paola Mapelli, et al.
La Radiologia Medica
|
May 7, 2025
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging
Tommaso Russo, Leonardo Quarta, Francesco Pellegrino, et al.
BJU International
|
July 8, 2026
Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study
Donato Cannoletta, Giorgio Brembilla, Mattia Longoni, et al.
European Urology Oncology
|
May 18, 2019
Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer
Armando Stabile, Paolo Dell'Oglio, Giorgio Gandaglia, et al.
Page
of 7